Sutro Biopharma (STRO) — Cash Flow Reinvestment Rate
Sutro Biopharma (STRO) has a Cash Flow Reinvestment Rate of 8.58x as of June 2024, reinvesting $81.13 Million (capex $756.00K plus investments $-80.38 Million) from operating cash flow of $9.46 Million. Check earnings quality score of Sutro Biopharma to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sutro Biopharma Cash Flow Reinvestment Rate (2018–2022)
Historical reinvestment intensity for Sutro Biopharma across 2 annual periods. Explore STRO long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Sutro Biopharma (2018–2022)
Year-by-year capital reinvestment analysis for Sutro Biopharma. For live market cap and broader valuation context, see STRO stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 12.08x | $42.88 Million | $3.55 Million | $7.86 Million | ▲ +90.9% |
| 2018 | 6.33x | $80.27 Million | $12.68 Million | $1.56 Million | — |